Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Federal Circuit
Biogen v. Serano – When is a Recombinant Polypeptide Novel?
When I posted about this Fed. Cir. decision (Biogen MA v. EMD Serano, Appeal no. 2019-1133 (Fed. Cir., Sept. 28, 2020) on October 12, 2020, I viewed it as a straightforward application of the maxim that an otherwise non-novel product … Continue reading
Biden’s Nominee to the Fed. Cir. is Perkins Coie Litigator
Tiffany P. Cunningham is a partner in the patent litigation practice of Perkins Coie. Importantly, she has a degree in Chemical Engineering from M.I.T. before receiving her J.D. from Harvard. The Court is in need of a judge that is … Continue reading
American Axle Petitions for Cert.
You may have noticed that I haven’t been posting since November. I feel like IP law has hunkered down and I find spats over jurisdiction and even the appeal urging the S. Ct. to validate IPR judgeships to be less … Continue reading
Prosecution Guidance from the Fed. Cir. – How to Forfeit Arguments During Your Appeal
Guest post from Tim Bianchi. The Federal Circuit decided an appeal in an ex parte prosecution for Google last week, which may be of interest to patent prosecutors (In re Google Technology Holdings LLC, Appeal No. 2019-1828, November 13, 2020)). … Continue reading